Victoria Wickenheisser,1 Emilia M. Zywot,2 Emily Rabjohns,1 Natalia Orlova,2 Christina M. Marvin,2 Song Ding,2 David S. Lawrence,1,2 Teresa R. Tarrant1
1Duke Univ. (United States) 2The Univ. of North Carolina at Chapel Hill (United States)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
We have developed a technology that facilitates the targeted delivery of glucocorticoids to arthritic joints thereby side-stepping systemic immune suppression while potentially improving efficacy. Our technology loads phototherapeutics inside of red blood cell (RBC) carriers. This ensures that the inactive, RBC-contained phototherapeutic drug is transported throughout the body and released from the RBC carrier only after triggered release by long-wavelength light. We have demonstrated that medications bound to vitamin B12 can be photo-released from RBCs using tissue penetrating, longwavelength red, far-red, and near infrared light in the collagen antibody-induced arthritis model.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Victoria Wickenheisser, Emilia M. Zywot, Emily Rabjohns, Natalia Orlova, Christina M. Marvin, Song Ding, David S. Lawrence, Teresa R. Tarrant, "Photo-released drugs: a targeted treatment approach for arthritis," Proc. SPIE 11223, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2020, 112230R (19 February 2020); https://doi.org/10.1117/12.2546949